Cargando…
miR-502 medaited histone methyltransferase SET8 expression is associated with outcome of esophageal squamous cell carcinoma
The histone methyltransferase SET8, whose expression is regulated by miR-502 though the binding site in the 3′ UTR of SET8, implicated in cancer development. Single nucleotide polymorphism (SNP) of rs16917496 located in the miR-502 and SET8 binding site was analyzed in esophageal squamous cell carci...
Autores principales: | Wang, Cuiju, Wu, Jianhua, Zhao, Yue, Guo, Zhanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015112/ https://www.ncbi.nlm.nih.gov/pubmed/27605386 http://dx.doi.org/10.1038/srep32921 |
Ejemplares similares
-
miR-502-mediated histone methyltransferase SET8 expression is associated with clear cell renal cell carcinoma risk
por: Zhang, Shenglei, et al.
Publicado: (2017) -
Downregulation of histone methyltransferase SET8 inhibits progression of hepatocellular carcinoma
por: Wu, Jianhua, et al.
Publicado: (2020) -
Polymorphism (rs16917496) at the miR-502 Binding Site of the Lysine Methyltransferase 5A (SET8) and Its Correlation with Colorectal Cancer in Iranians
por: Mosallayi, Meysam, et al.
Publicado: (2017) -
The histone methyltransferase SET8 is required for S-phase progression
por: Jørgensen, Stine, et al.
Publicado: (2007) -
Single nucleotide polymorphisms in the mitochondrial displacement loop and outcome of esophageal squamous cell carcinoma
por: Zhang, Ruixing, et al.
Publicado: (2010)